Implementation of an HPV vaccination program in Eldoret, Kenya: results from a qualitative assessment by key stakeholders
- PMID: 26358701
- PMCID: PMC4566420
- DOI: 10.1186/s12889-015-2219-y
Implementation of an HPV vaccination program in Eldoret, Kenya: results from a qualitative assessment by key stakeholders
Abstract
Background: Cervical cancer strikes hard in low-resource regions yet primary prevention is still rare. Pilot projects have however showed that Human Papillomavirus (HPV) vaccination programs can attain high uptake. Nevertheless, a study accompanying a vaccination demonstration project in Eldoret, Kenya, revealed less encouraging outcomes: uptake during an initial phase targeting ten schools (i.e., 4000 eligible girls), was low and more schools had to be included to reach the proposed number of 3000 vaccinated girls. The previously conducted study also revealed that many mothers had not received promotional information which had to reach them through schools: teachers were sensitized by health staff and asked to invite students and parents for HPV vaccination in the referral hospital. In this qualitative study, we investigate factors that hampered promotion and vaccine uptake.
Methods: Focus group discussions (FGD) with teachers (4) and fathers (3) were organized to assess awareness and attitudes towards the vaccination program, cervical cancer and the HPV vaccine, as well as a FGD with the vaccinators (1) to discuss the course of the program and potential improvements. Discussions were recorded, transcribed, translated, and analyzed using thematic analysis In addition, a meeting with the program coordinator was set up to reflect upon the program and the results of the FGD, and to formulate recommendations for future programs.
Results: Cervical cancer was poorly understood by fathers and teachers and mainly linked with nonconforming sexual behavior and modern lifestyle. Few had heard about the vaccination opportunity: feeling uncomfortable to discuss cervical cancer and not considering it as important had hampered information flow. Teachers requested more support from health staff to address unexpected questions from parents. Non-uptake was also the result of distrust towards new vaccines. Schools entering the program in the second phase reacted faster: they were better organized, e.g., in terms of transport, while the community was already more familiarized with the vaccine.
Conclusions: Close collaboration between teachers and health staff is crucial to obtain high HPV vaccine uptake among schoolgirls. Promotional messages should, besides providing correct information, tackle misbeliefs, address stigma and stress the priority to vaccinate all, regardless of lifestyle. Monitoring activities and continuous communication could allow for detection of rumors and unequal uptake in the community.
Similar articles
-
Determinants of acceptance and subsequent uptake of the HPV vaccine in a cohort in Eldoret, Kenya.PLoS One. 2014 Oct 9;9(10):e109353. doi: 10.1371/journal.pone.0109353. eCollection 2014. PLoS One. 2014. PMID: 25299646 Free PMC article.
-
Schoolteachers' experiences of implementing school-based vaccination programs against human papillomavirus in a Chinese community: a qualitative study.BMC Public Health. 2019 Nov 12;19(1):1514. doi: 10.1186/s12889-019-7878-7. BMC Public Health. 2019. PMID: 31718611 Free PMC article.
-
Attitudes towards human papillomavirus vaccination among African parents in a city in the north of England: a qualitative study.Reprod Health. 2016 Aug 22;13(1):97. doi: 10.1186/s12978-016-0209-x. Reprod Health. 2016. PMID: 27549328 Free PMC article.
-
National introduction of human papillomavirus (HPV) vaccine in Tanzania: Programmatic decision-making and implementation.Vaccine. 2022 Mar 31;40 Suppl 1(Suppl 1):A2-A9. doi: 10.1016/j.vaccine.2021.04.025. Epub 2021 May 4. Vaccine. 2022. PMID: 33962839 Free PMC article. Review.
-
Implementing HPV vaccines: public knowledge, attitudes, and the need for education.Int Q Community Health Educ. 2010-2011;31(1):71-98. doi: 10.2190/IQ.31.1.f. Int Q Community Health Educ. 2010. PMID: 21576068 Review.
Cited by
-
Stakeholders' Understandings of Human Papillomavirus (HPV) Vaccination in Sub-Saharan Africa: A Rapid Qualitative Systematic Review.Vaccines (Basel). 2021 May 12;9(5):496. doi: 10.3390/vaccines9050496. Vaccines (Basel). 2021. PMID: 34065961 Free PMC article. Review.
-
Biopsychosocial risk factors and knowledge of cervical cancer among young women: A case study from Kenya to inform HPV prevention in Sub-Saharan Africa.PLoS One. 2020 Aug 20;15(8):e0237745. doi: 10.1371/journal.pone.0237745. eCollection 2020. PLoS One. 2020. PMID: 32817627 Free PMC article.
-
Uptake of three doses of HPV vaccine by primary school girls in Eldoret, Kenya; a prospective cohort study in a malaria endemic setting.BMC Cancer. 2018 May 11;18(1):557. doi: 10.1186/s12885-018-4382-x. BMC Cancer. 2018. PMID: 29751793 Free PMC article.
-
Understanding cervical cancer prevention in Africa: a qualitative systematic review of the role of men.BMJ Open. 2024 Dec 23;14(12):e080416. doi: 10.1136/bmjopen-2023-080416. BMJ Open. 2024. PMID: 39719283 Free PMC article.
-
School Teachers' Perceptions of Adolescent Human Papillomavirus (HPV) Vaccination: A Systematic Review.Vaccines (Basel). 2024 Mar 27;12(4):361. doi: 10.3390/vaccines12040361. Vaccines (Basel). 2024. PMID: 38675743 Free PMC article. Review.
References
-
- Estimated cancer incidence, mortality and prevalence worldwide in 2012. [http://globocan.iarc.fr/Pages/fact_sheets_population.aspx]
-
- Steben M, Jeronimo J, Wittet S, Lamontagne DS, Ogilvie G, Jensen C, Smith J, Franceschi S. Upgrading public health programs for human papillomavirus prevention and control is possible in low- and middle-income countries. Vaccine. 2012;30(Suppl 5):F183–91. doi: 10.1016/j.vaccine.2012.06.031. - DOI - PubMed
-
- Paavonen J, Naud P, Salmeron J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet. 2009;374(9686):301–14. doi: 10.1016/S0140-6736(09)61248-4. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical